Canopy Growth (CGC) Shares Outstanding (Diluted Average) (2019 - 2025)

Canopy Growth's (CGC) quarterly Shares Outstanding (Diluted Average) came in at $193.3 million in Q4 2025, up 144.82% year-on-year from $79.0 million in Q4 2024, and up 14.97% quarter-over-quarter from $168.1 million in Q3 2025.

Canopy Growth (CGC) Shares Outstanding (Diluted Average) (2019 - 2025) Analysis & Trends

Canopy Growth has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $193.3 million for Q4 2025.

  • Shares Outstanding (Diluted Average) for Q4 2025 came in at $193.3 million, up 144.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $193.3 million (up 144.82% YoY), and the FY2025 annual result was $75.0 million, up 35.05% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $193.3 million for Q4 2025 at Canopy Growth, up from $168.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $361.6 million in Q3 2022 to a low of $30.9 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $77.0 million (2024), against an average of $150.8 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) plunged 89.48% in 2022 and soared 176.18% in 2025, its largest moves.
  • Canopy Growth's Shares Outstanding (Diluted Average) stood at $312.4 million in 2021, then plunged by 88.54% to $35.8 million in 2022, then surged by 70.07% to $60.9 million in 2023, then gained by 29.64% to $79.0 million in 2024, then jumped by 144.82% to $193.3 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $193.3 million (Q4 2025), $168.1 million (Q3 2025), and $135.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 103.40 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn -
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 101.11 Mn
10 Canopy Growth 11.16 Mn -137.54 Mn 15.39 Mn 193.32 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 193.32 Mn
Sep 30, 2025 168.15 Mn
Jun 30, 2025 135.91 Mn
Mar 31, 2025 74.96 Mn
Dec 31, 2024 78.96 Mn
Sep 30, 2024 60.88 Mn
Jun 30, 2024 57.94 Mn
Mar 31, 2024 55.50 Mn
Dec 31, 2023 60.91 Mn
Sep 30, 2023 53.43 Mn
Jun 30, 2023 40.98 Mn
Mar 31, 2023 34.30 Mn
Dec 31, 2022 35.81 Mn
Sep 30, 2022 361.59 Mn
Jun 30, 2022 312.53 Mn
Mar 31, 2022 30.89 Mn
Dec 31, 2021 312.43 Mn
Sep 30, 2021 325.04 Mn
Jun 30, 2021 329.11 Mn
Mar 31, 2021 293.65 Mn